Rheumatoid arthritis drugs for schizophrenia?

Peter F. Buckley, Brian J Miller

Research output: Contribution to journalArticle

Abstract

Any relationship between treatment of rheumatoid arthritis and the current treatment of schizophrenia seems, at first glance, far-fetched. And yet, in a relatively short period of intensive research work, the field of schizophrenia research has come to appreciate that there are fundamental immunological associations with schizophrenia. Several groups have conducted studies of antirheu-matic drugs—from various nonsteroidal anti-inflammatory drugs to more selective anticytokine monoclonal antibodies—in patients with schizophrenia. The results and focus of this work are detailed in this article.

Original languageEnglish (US)
Pages (from-to)232-236
Number of pages5
JournalPsychiatric Annals
Volume48
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Rheumatoid Arthritis
Schizophrenia
Pharmaceutical Preparations
Research
Anti-Inflammatory Agents
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Rheumatoid arthritis drugs for schizophrenia? / Buckley, Peter F.; Miller, Brian J.

In: Psychiatric Annals, Vol. 48, No. 5, 01.05.2018, p. 232-236.

Research output: Contribution to journalArticle

Buckley, Peter F. ; Miller, Brian J. / Rheumatoid arthritis drugs for schizophrenia?. In: Psychiatric Annals. 2018 ; Vol. 48, No. 5. pp. 232-236.
@article{d63b357d68e349e1945e662c9658c212,
title = "Rheumatoid arthritis drugs for schizophrenia?",
abstract = "Any relationship between treatment of rheumatoid arthritis and the current treatment of schizophrenia seems, at first glance, far-fetched. And yet, in a relatively short period of intensive research work, the field of schizophrenia research has come to appreciate that there are fundamental immunological associations with schizophrenia. Several groups have conducted studies of antirheu-matic drugs—from various nonsteroidal anti-inflammatory drugs to more selective anticytokine monoclonal antibodies—in patients with schizophrenia. The results and focus of this work are detailed in this article.",
author = "Buckley, {Peter F.} and Miller, {Brian J}",
year = "2018",
month = "5",
day = "1",
doi = "10.3928/00485713-20180405-01",
language = "English (US)",
volume = "48",
pages = "232--236",
journal = "Psychiatric Annals",
issn = "0048-5713",
publisher = "Slack Incorporated",
number = "5",

}

TY - JOUR

T1 - Rheumatoid arthritis drugs for schizophrenia?

AU - Buckley, Peter F.

AU - Miller, Brian J

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Any relationship between treatment of rheumatoid arthritis and the current treatment of schizophrenia seems, at first glance, far-fetched. And yet, in a relatively short period of intensive research work, the field of schizophrenia research has come to appreciate that there are fundamental immunological associations with schizophrenia. Several groups have conducted studies of antirheu-matic drugs—from various nonsteroidal anti-inflammatory drugs to more selective anticytokine monoclonal antibodies—in patients with schizophrenia. The results and focus of this work are detailed in this article.

AB - Any relationship between treatment of rheumatoid arthritis and the current treatment of schizophrenia seems, at first glance, far-fetched. And yet, in a relatively short period of intensive research work, the field of schizophrenia research has come to appreciate that there are fundamental immunological associations with schizophrenia. Several groups have conducted studies of antirheu-matic drugs—from various nonsteroidal anti-inflammatory drugs to more selective anticytokine monoclonal antibodies—in patients with schizophrenia. The results and focus of this work are detailed in this article.

UR - http://www.scopus.com/inward/record.url?scp=85046726020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046726020&partnerID=8YFLogxK

U2 - 10.3928/00485713-20180405-01

DO - 10.3928/00485713-20180405-01

M3 - Article

AN - SCOPUS:85046726020

VL - 48

SP - 232

EP - 236

JO - Psychiatric Annals

JF - Psychiatric Annals

SN - 0048-5713

IS - 5

ER -